A study by Triton Market Research with the title ‘Global Clinical Nutrition Market,’ covers the Global Analysis and Forecast for 2019-2028 by Route of Administration (Enteral, Parenteral, Oral), by Application (Gastrointestinal Disorders, Neurological Disorders, Cancer, Metabolic Disorders, Other Applications), by End-user (Pediatric, Adults, Geriatric), and by Geographical Region (Latin America, North America, Europe, Middle East and Africa, Asia-Pacific).
Clinical nutrition refers to pharmaceutical supplements that are designed for patients who are unable to develop the needed nutritional requirement naturally in their bodies. They are used in the treatment of diseases that affect the metabolism of the patient’s body.
Request Free Sample of the Global Clinical Nutrition Market Report @ https://www.tritonmarketresearch.com/reports/clinical-nutrition-market#request-free-sample
As per the report, the global clinical nutrition market is likely to generate $48.58 billion by the year 2028. The market is predicted to expand at a CAGR of 5.27% in the forthcoming years (2019-2028).
The increasing number of people suffering from chronic health diseases, like anorexia, disaccharidase intolerance, cachexia and food allergy, that require clinical nutrition care is driving the growth of the global clinical nutrition market. Patients of these syndromes generally have nutritional deficiency problems, and hence, require additional supplement intake. In recent years, there has been an alarming increase in the nutritional problems being faced by people across the world. However, the complications associated with enteral feeding are restraining market growth. It is one of the major clinical delivery modes, but faces GI (gastrointestinal), metabolic and mechanical complications.
The clinical nutrition market is segmented into three parts, route of administration, application and end-user. The first segment, route of administration, includes enteral, parenteral and oral. The second segment, application, is divided into gastrointestinal disorders, neurological disorders, cancer, metabolic disorders, and other applications. The last segment, end-user, is trifurcated into pediatric, adults, and geriatric.
Considering the geographical landscape, the Asia-Pacific is likely to show the fastest growth in the global clinical nutrition market during the projected period. The proportion of the geriatric population is increasing in many countries, including China, Japan, India and South Korea. These individuals are prone to suffer from loss of appetite or digestive problems, which may require the intake of additional supplements through the enteral or parenteral route. Non-communicable diseases are generally common in the older generation. Also, there is a rapid growth of gastrointestinal diseases in ASEAN countries over the last two decades. It is one of the most common disorders in the geriatric population, requiring clinical nutrition in the form of supplements, so as to maintain the body-energy balance. Besides, there is also an increase in the number of women who are anemic and require iron supplements additionally. All these factors are expected to push the demand for clinical nutrition in the Asia-Pacific.
Some leading companies in the clinical nutrition market are Otsuka Holdings Co Ltd, Baxter International Inc, Meiji Holdings Co Ltd, American Regent Inc, Abbott Laboratories, Sanofi SA, Lonza Inc, Sichuan Kelun Pharmaceutical Co Ltd, BASF SE, B Braun, Nestle Health Science, Exela Pharma Sciences, Grifols SA, Danone, Avadel Pharmaceuticals and Reckitt Benckiser Group Plc.
Purchase this Report @ https://www.tritonmarketresearch.com/reports/clinical-nutrition-market#purchase-option
Question & Answer: Clinical Nutrition Market
Question 1: Which factors are driving the growth of the global clinical nutrition market?
Answer: The increasing number of people suffering from chronic health diseases, like anorexia, disaccharidase intolerance, cachexia and food allergy, that require clinical nutrition care is driving the growth of the global clinical nutrition market. Patients of these syndromes generally have nutritional deficiency problems, and hence, require additional supplement intake. In recent years, there has been an alarming increase in the nutritional problems being faced by people across the world.
Question 2: What factors are restraining the global clinical nutrition market growth?
Answer: The complications associated with enteral feeding are restraining market growth. It is one of the major clinical delivery modes, but faces GI (gastrointestinal), metabolic and mechanical complications.
Question 3: How is Asia-Pacific affecting the global clinical nutrition market outlook?
Answer: Considering the geographical landscape, the Asia-Pacific is likely to show the fastest growth in the global clinical nutrition market during the projected period. The proportion of the geriatric population is increasing in many countries, including China, Japan, India and South Korea. These individuals are prone to suffer from loss of appetite or digestive problems, which may require the intake of additional supplements through the enteral or parenteral route.
Non-communicable diseases are generally common in the older generation. Also, there is a rapid growth of gastrointestinal diseases in ASEAN countries over the last two decades. It is one of the most common disorders in the geriatric population, requiring clinical nutrition in the form of supplements, so as to maintain the body-energy balance. Besides, there is also an increase in the number of women who are anemic and require iron supplements additionally. All these factors are expected to push the demand for clinical nutrition in the Asia-Pacific.
Question 4: Which are some of the leading companies in the clinical nutrition market?
Answer: Some leading companies in the clinical nutrition market are Otsuka Holdings Co Ltd, Baxter International Inc, Meiji Holdings Co Ltd, American Regent Inc, Abbott Laboratories, Sanofi SA, Lonza Inc, Sichuan Kelun Pharmaceutical Co Ltd, BASF SE, B Braun, Nestle Health Science, Exela Pharma Sciences, Grifols SA, Danone, Avadel Pharmaceuticals and Reckitt Benckiser Group Plc.
Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/